在达到 MRD 阴性缓解后出现可测量残留疾病（MRD）复发的急性髓系白血病患者中，治疗干预的临床结果和影响。
Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission.
机构信息
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
出版信息
Am J Hematol. 2022 Nov;97(11):E408-E411. doi: 10.1002/ajh.26698. Epub 2022 Sep 8.
PMID:36054774
Abstract
Recurrence of MRD in AML is associated with imminent relapse unless intervened upon. Change in chemotherapy regimen and/or immediate transplant improve outcomes.
摘要
AML 患者的 MRD 复发与即将发生的疾病复发相关，除非进行干预。改变化疗方案和/或立即进行移植可以改善预后。
Zotero 插件